Trinity Biotech (TRIB) Revenue & Revenue Breakdown
Trinity Biotech Revenue Highlights
Latest Revenue (Y)
$56.83M
Latest Revenue (Q)
$14.70M
Main Segment (Y)
Point-of-Care
Main Geography (Y)
America
Trinity Biotech Revenue by Period
Trinity Biotech Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $56.83M | -24.00% |
| 2022-12-31 | $74.78M | -19.56% |
| 2021-12-31 | $92.97M | -8.84% |
| 2020-12-31 | $101.98M | 12.77% |
| 2019-12-31 | $90.44M | -6.80% |
| 2018-12-31 | $97.03M | -2.12% |
| 2017-12-31 | $99.14M | -0.47% |
| 2016-12-31 | $99.61M | -0.58% |
| 2015-12-31 | $100.19M | -4.46% |
| 2014-12-31 | $104.87M | 14.97% |
| 2013-12-31 | $91.22M | 10.55% |
| 2012-12-31 | $82.51M | 5.85% |
| 2011-12-31 | $77.95M | -13.04% |
| 2010-12-31 | $89.64M | -28.81% |
| 2009-12-31 | $125.91M | -10.16% |
| 2008-12-31 | $140.14M | -2.42% |
| 2007-12-31 | $143.62M | 21.02% |
| 2006-12-31 | $118.67M | 20.41% |
| 2005-12-31 | $98.56M | 23.29% |
| 2004-12-31 | $79.94M | 21.73% |
| 2003-12-31 | $65.68M | 26.35% |
| 2002-12-31 | $51.98M | 40.24% |
| 2001-12-31 | $37.06M | 24.62% |
| 2000-12-31 | $29.74M | 13.94% |
| 1999-12-31 | $26.10M | 12.52% |
| 1998-12-31 | $23.20M | 38.10% |
| 1997-12-31 | $16.80M | 133.33% |
| 1996-12-31 | $7.20M | -27.27% |
| 1995-12-31 | $9.90M | 90.38% |
| 1994-12-31 | $5.20M | 116.67% |
| 1994-02-28 | $2.40M | - |
Trinity Biotech generated $56.83M in revenue during NA 2023, up -24.00% compared to the previous quarter, and up 58.57% compared to the same period a year ago.
Trinity Biotech Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $14.70M | 9.50% |
| 2023-12-31 | $13.43M | -8.51% |
| 2023-09-30 | $14.68M | 5.61% |
| 2023-06-30 | $13.90M | -6.28% |
| 2023-03-31 | $14.83M | -17.78% |
| 2022-12-31 | $18.04M | -7.52% |
| 2022-09-30 | $19.50M | 5.62% |
| 2022-06-30 | $18.46M | -1.66% |
| 2022-03-31 | $18.78M | -3.84% |
| 2021-12-31 | $19.52M | -11.27% |
| 2021-09-30 | $22.00M | -14.86% |
| 2021-06-30 | $25.84M | 0.97% |
| 2021-03-31 | $25.59M | -21.89% |
| 2020-12-31 | $32.77M | 2.35% |
| 2020-09-30 | $32.01M | 99.79% |
| 2020-06-30 | $16.02M | -24.33% |
| 2020-03-31 | $21.18M | -0.66% |
| 2019-12-31 | $21.32M | -13.32% |
| 2019-09-30 | $24.59M | 9.32% |
| 2019-06-30 | $22.50M | 2.14% |
| 2019-03-31 | $22.03M | -10.19% |
| 2018-12-31 | $24.52M | 3.42% |
| 2018-09-30 | $23.71M | -5.16% |
| 2018-06-30 | $25.00M | 5.05% |
| 2018-03-31 | $23.80M | -3.07% |
| 2017-12-31 | $24.55M | -4.11% |
| 2017-09-30 | $25.60M | 0.61% |
| 2017-06-30 | $25.45M | 8.12% |
| 2017-03-31 | $23.54M | -0.61% |
| 2016-12-31 | $23.68M | -9.36% |
| 2016-09-30 | $26.13M | -0.61% |
| 2016-06-30 | $26.29M | 11.79% |
| 2016-03-31 | $23.52M | -5.70% |
| 2015-12-31 | $24.94M | -3.20% |
| 2015-09-30 | $25.76M | 6.20% |
| 2015-06-30 | $24.26M | -3.89% |
| 2015-03-31 | $25.24M | -5.40% |
| 2014-12-31 | $26.68M | -1.77% |
| 2014-09-30 | $27.16M | 4.45% |
| 2014-06-30 | $26.00M | 3.92% |
| 2014-03-31 | $25.02M | -1.69% |
| 2013-12-31 | $25.45M | 5.53% |
| 2013-09-30 | $24.12M | 13.18% |
| 2013-06-30 | $21.31M | 4.84% |
| 2013-03-31 | $20.33M | -2.38% |
| 2012-12-31 | $20.82M | -0.13% |
| 2012-09-30 | $20.85M | 0.20% |
| 2012-06-30 | $20.81M | 3.91% |
| 2012-03-31 | $20.03M | 0.06% |
| 2011-12-31 | $20.01M | 0.94% |
| 2011-09-30 | $19.83M | 1.91% |
| 2011-06-30 | $19.45M | 4.29% |
| 2011-03-31 | $18.65M | -3.08% |
| 2010-12-31 | $19.25M | 2.66% |
| 2010-09-30 | $18.75M | -17.14% |
| 2010-06-30 | $22.63M | -22.01% |
| 2010-03-31 | $29.01M | -5.78% |
| 2009-12-31 | $30.79M | -2.87% |
| 2009-09-30 | $31.70M | -1.85% |
| 2009-06-30 | $32.30M | 3.84% |
| 2009-03-31 | $31.11M | -8.54% |
| 2008-12-31 | $34.01M | -4.42% |
| 2008-09-30 | $35.58M | -1.97% |
| 2008-06-30 | $36.30M | 5.96% |
| 2008-03-31 | $34.25M | 100.00% |
| 2007-12-31 | - | - |
Trinity Biotech generated $14.70M in revenue during Q1 2024, up 9.50% compared to the previous quarter, and up 81.53% compared to the same period a year ago.
Trinity Biotech Revenue Breakdown
Trinity Biotech Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Point-of-Care | $9.09M | $9.21M | $10.34M | $9.21M | $11.39M |
| Clinical laboratory services | - | - | $7.93M | $8.48M | - |
| Clinical laboratory goods | - | - | $74.70M | $84.28M | - |
| Clinical laboratory | - | - | - | - | $68.13M |
| Laboratory services | - | - | - | - | $10.91M |
Trinity Biotech's latest annual revenue breakdown by segment (product or service), as of Dec 23: Point-of-Care (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 22 |
|---|---|
| Clinical Laboratory | $29.53M |
| Laboratory Services | $3.70M |
Trinity Biotech's latest quarterly revenue breakdown by segment (product or service), as of Jun 22: Clinical Laboratory (88.86%), and Laboratory Services (11.14%).
Trinity Biotech Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| America | $32.28M | $40.18M | - | - | - |
| Ireland | $12.72M | $28.23M | - | - | - |
| Americas | - | - | $57.80M | $70.41M | $52.18M |
| Clinical laboratory services | - | - | $7.93M | - | - |
| Clinical laboratory goods | - | - | $74.70M | - | - |
| Asia / Africa | - | - | $25.50M | $22.57M | $27.69M |
| Point-of-Care | - | - | $10.34M | - | - |
| Other Countries | - | - | - | - | - |
| Europe (including Ireland) | - | - | - | $9.01M | $10.57M |
Trinity Biotech's latest annual revenue breakdown by geography, as of Dec 23: America (71.73%), and Ireland (28.27%).
Quarterly Revenue by Country
| Country | Jun 22 |
|---|---|
| Clinical Laboratory | $29.53M |
| Laboratory Services | $3.70M |
Trinity Biotech's latest quarterly revenue breakdown by geography, as of Jun 22: Clinical Laboratory (88.86%), and Laboratory Services (11.14%).
Trinity Biotech Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SHC | Sotera Health | $1.05B | $276.59M |
| GTH | Genetron | $650.71M | $201.32M |
| NOTV | Inotiv | $572.42M | $105.79M |
| CSTL | Castle Biosciences | $219.79M | $87.00M |
| OLK | Olink AB (publ) | $169.91M | $28.59M |
| LAB | Standard BioTools | $106.34M | $37.20M |
| FONR | FONAR | $98.65M | $25.72M |
| STIM | Neuronetics | $71.35M | $16.45M |
| MDXH | MDxHealth SA | $70.19M | $19.83M |
| TRIB | Trinity Biotech | $56.83M | $14.70M |
| XGN | Exagen | $52.55M | $15.06M |
| BDSX | Biodesix | $49.09M | $14.82M |
| ACRS | Aclaris Therapeutics | $31.25M | $2.40M |
| PRE | Prenetics Global | $21.74M | $6.41M |
| SERA | Sera Prognostics | $306.00K | - |
| NDRA | ENDRA Life Sciences | - | - |
TRIB Revenue FAQ
What is Trinity Biotech’s yearly revenue?
Trinity Biotech's yearly revenue for 2023 was $56.83M, representing a decrease of -24.00% compared to 2022. The company's yearly revenue for 2022 was $74.78M, representing a decrease of -19.56% compared to 2021. TRIB's yearly revenue for 2021 was $92.96M, representing a decrease of -8.84% compared to 2020.
What is Trinity Biotech’s quarterly revenue?
Trinity Biotech's quarterly revenue for Q1 2024 was $14.7M, a 9.50% increase from the previous quarter (Q4 2023), and a -0.84% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $13.43M, a -8.51% decrease from the previous quarter (Q3 2023), and a -25.55% decrease year-over-year (Q4 2022). TRIB's quarterly revenue for Q3 2023 was $14.68M, a 5.61% increase from the previous quarter (Q2 2023), and a -24.74% decrease year-over-year (Q3 2022).
What is Trinity Biotech’s revenue growth rate?
Trinity Biotech's revenue growth rate for the last 3 years (2021-2023) was -38.87%, and for the last 5 years (2019-2023) was -37.16%.
What are Trinity Biotech’s revenue streams?
Trinity Biotech's revenue streams in c 23 are Point-of-Care
What is Trinity Biotech’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Trinity Biotech was Point-of-Care. This segment made a revenue of $9.09M, representing 100.00% of the company's total revenue.